Dr. Mohammed Rafiyath is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10350 E Drexel Rd Ste 204210
Tucson, AZ 85747Phone+1 520-625-6600Fax+1 520-625-8467
Education & Training
- Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- New York Medical CollegeClass of 2012
- Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 2007 - 2009
Certifications & Licensure
- AZ State Medical License 2015 - 2026
- ND State Medical License 2012 - 2018
- MN State Medical License 2012 - 2017
- NY State Medical License 2009 - 2013
- NJ State Medical License 2007 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 113 citationsFirst-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinibGuoqing Wei, Shamudheen M. Rafiyath, Delong Liu
Journal of Hematology & Oncology. 2010-11-26 - 181 citationsComparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisShamudheen M. Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba
Experimental Hematology & Oncology. 2012-04-23 - 34 citationsMalignant glomus tumor of kidney: the first reported case and review of literature.Gurpreet Lamba, Shamudheen M. Rafiyath, Harneet Kaur, Sameena Khan, Parminder Singh
Human Pathology. 2011-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: